Clinical Trial Detail

NCT ID NCT03066206
Title Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Poziotinib

Age Groups: senior adult

Additional content available in CKB BOOST